Glass House Brands (GLAS) EBITDA Margin Growth (1y) (2021 - 2025)
Glass House Brands (GLAS) EBITDA Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn | -2,797.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 842.00 |
| Jun 30, 2024 | 213.00 |
| Jun 30, 2023 | -5,207.00 |
| Dec 31, 2022 | 868.00 |
| Sep 30, 2022 | -2,163.00 |
| Jun 30, 2022 | 5,928.00 |
| Mar 31, 2022 | 7,805.00 |
| Dec 31, 2021 | -441.28 Mn |
| Sep 30, 2021 | 2,947.00 |
| Mar 31, 2021 | 3,220.00 |